Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Urologic oncology 2013 Oct 31 (7): 1350-7.
Ahmad Shiekh Tanveer, Arjumand Wani, Seth Amlesh, Nafees Sana, Rashid Summya, Ali Nemat, Hamiza Oday O, Sultana Sarw
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: